Anticancer Research, abgekürzt Anticancer Res., ist eine wissenschaftliche Fachzeitschrift, die vom International Institute for Anticancer Research veröffentlicht Expert Review of Anticancer Therapy, abgekürzt Expert. Rev. Anticancer Ther., ist eine wissenschaftliche Fachzeitschrift, die vom Taylor & Francis-Verlag Shimizu: Experimental anticancer studies. XXX. Factors influencing the streptolysin S-forming ability of streptococci having anticancer activity. In: Jpn differentiating agents with different modes of action in colon cancer cells. In: Anticancer Drugs. 2006, 17, 5, S. 521-6. PMID 16702808 Normdaten (Sachbegriff): GND: characterization of gamma-polyglutamic acid nanoparticles for controlled anticancer drug release. In: Critical reviews in biotechnology. Band 28, Nummer 2 promising tumor marker in the diagnosis of gastro-intestinal cancer. In: Anticancer Res. 20(6D), 2000 Nov-Dec, S. 4965–4968. PMID 11326648. D. K. Dhar, S development of an anticancer agent. Int J Biochem Cell Biol. 39, 1388–1405, 2007 M. Jung: Inhibitor of Histone Decetylase as New Anticancer Agents. Current PMID 15917311. M. A. Jordan, W. Leslie: Microtubules as a Target for Anticancer Drugs. In: Nature Reviews Cancer. 4, Nr. 4, 2004, S. 253–265. doi:10 K, Sasaki Y: Pharmacogenomics in drug-metabolizing enzymes catalyzing anticancer drugs for personalized cancer chemotherapy. In: Curr. Drug Metab.. 8, Autocrine motility factor receptor: a clinical review. In: Expert Rev Anticancer Ther. 8 2008:207-17. PMID 18279062 K. Iwanami et al.: Crucial role of Oncology (2004), Scientific Advisory Board des International Institute of Anticancer Research (2004), International Journal IN VIVO (2007), ISRN Obstetrics standard-dose chemotherapy in a breast cancer patient: a case report. In: Anticancer Research Band 26, Nummer 2B, 2006 Mar-Apr, S. 1627–1630, ISSN 0250-7005 strategies of Mycobacterium tuberculosis in macrophage phagosomes. In: Anticancer Research Band 29, Nummer 3, März 2009, S. 907–910, ISSN 0250-7005. PMID Kuzel: Denileukin diftitox: a concise clinical review. In: Expert Rev Anticancer Ther. 5, 2005, S. 33–38. PMID 15757436 (Review) C. D. Carretero-Margolis 11895152 (englisch) S. Mazurek, E. Eigenbrodt: The tumor metabolome. In: Anticancer Res. 23, (2003), S. 1149–1154. PMID 12820363 (englisch) metabolic database of folypoly-gamma-glutamate synthetase substrates and inhibitors. In: Curr Med Chem Anticancer Agents. 2, Nr. 3, Mai 2002, S. 331–55. PMID 12678736. Singh u. a.: Microtubule assembly dynamics: An attractive target for anticancer drugs. In: IUBMB Life 60, 2008, S. 368–375, PMID 18384115. K. Rathinasamy glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin. In: FEBS Lett.. 580, Nr. 15, Juni 2006, S. 3746–52 Oncolytic viruses: a novel form of immunotherapy. In: Expert Review of Anticancer Therapy. Band 8, Nummer 10, Oktober 2008, S. 1581–1588, ISSN 1744-8328 Wissenschaft (idw-online.de), abgerufen am 24. August 2015. H. Chung u. a.: Anticancer effects of wogonin in both estrogen receptor-positive and -negative human „Biological and Pharmacological Roles of N6-Isopentenyladenosine: An Emerging Anticancer Drug“, Anti-Cancer Agents in Medicinal Chemistry, 2008, 8 (2), S. 200–204 Catherine M. Clavel, Paul J. Dyson: Synthesis, characterization and invitro anticancer activity of highly cytotoxic trithiolato diruthenium complexes of the Bernhard Lippert (Ed.): Cisplatin, Chemistry and Biochemistry of a Leading Anticancer Drug. Wiley-VCH (1999), ISBN 3-906390-20-9 Bernhard Lippert, Wolfgang 3002621. T. P. Johnston und J. A. Montgomery: Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems. In: Cancer Triphosphate (ATP). Abgerufen am 14. September 2012. Neubauer et al., Anticancer Res. 28, 949 (2008) Lau et al., Biomed Pharmacother 61, 562 (2007) Chen